Media ❯ Television ❯ Business News ❯ CNBC

Jim Cramer

Cramer Backs Abbott’s Exact Sciences Buy, Calling It a Pivotal Diagnostics Move

Cramer says regulatory approval now stands as the key test for Abbott’s diagnostics bet.

Palantir Sinks for the Week After Blowout Quarter as Karp Rebukes Short Sellers

Markets Reward AI Monetization as Big Tech Lifts Capex and Meta Stumbles

Cramer Touts GE Vernova as Only Nuclear Builder After Strong Orders, Data-Center Focus

Netflix Shares Slide After Q3 EPS Miss Tied to $620 Million Brazil Tax Hit

Cramer Spotlights Comerica–Fifth Third Merger, Backs Ford and Palantir, Says Amazon Event Could Matter

Morgan Stanley Upgrades Micron to Overweight on AI-Memory Strength

Nvidia Ties Up to $100 Billion to OpenAI, Pledging 10GW of Systems From 2026

Palantir Sheds $73 Billion in Six-Day Slide as Valuation Fight Reignites